US Stock MarketDetailed Quotes
ACOGF ALPHA COGNITION INC
- 0.596
- -0.004-0.67%
15min DelayTrading Jul 23 15:11 ET
89.36MMarket Cap-3725P/E (TTM)
0.653High0.590Low367.36KVolume0.592Open0.600Pre Close223.55KTurnover0.25%Turnover RatioLossP/E (Static)149.93MShares0.74052wk High596.00P/B89.36MFloat Cap0.16452wk Low--Dividend TTM149.93MShs Float0.740Historical High--Div YieldTTM10.43%Amplitude0.164Historical Low0.608Avg Price1Lot Size
About ALPHA COGNITION INC Company
Alpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Company Profile
SymbolACOGF
Company NameALPHA COGNITION INC
Founded2000
CEOMr. Michael McFadden
MarketPink Market
Employees19
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address750 West Pender Street,Suite 1200
CityVancouver
ProvinceBritish Columbia
CountryCanada
Zip CodeV6C 2T8
Company Executives
- Name
- Position
- Salary
- Michael McFadden
- Chief Executive Officer and Director
- --
- Dr. Cedric O'Gorman, M.D.
- Chief Medical Officer
- --
- Donald Kalkofen
- Chief Financial Officer
- --
- Dr. Denis Kay
- Chief Scientific Officer
- --
- Lauren D’Angelo
- Chief Commercial Officer
- --
- Len Mertz
- Chairman of the Board
- --
- Kenneth A. Cawkell, L.L.B.
- Corporate Secretary and Director
- --
- Rajeev Bakshi
- Independent Director
- --
- John Havens
- Independent Director
- --
- Phillip Mertz
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
